Inhibitory Effect of Silencing PCAF Gene on Growth and Angiogenesis of Human Adrenocortical Carcinoma Xenograft in Nude Mice

CHEN Shuai; HU Weilie; OUYANG Keyu; NIE Qiwei; WANG Wei

doi:10.3971/j.issn.1000-8578.2015.05.007

Cancer Research on Prevention and Treatment > 2015 > 42(05): 454-458. > DOI: 10.3971/j.issn.1000-8578.2015.05.007

CHEN Shuai, HU Weilie, OUYANG Keyu, NIE Qiwei, WANG Wei. Inhibitory Effect of Silencing PCAF Gene on Growth and Angiogenesis of Human Adrenocortical Carcinoma Xenograft in Nude Mice[J]. Cancer Research on Prevention and Treatment, 2015, 42(05): 454-458. DOI: 10.3971/j.issn.1000-8578.2015.05.007

Citation:

PDF (10828 KB)

Inhibitory Effect of Silencing PCAF Gene on Growth and Angiogenesis of Human Adrenocortical Carcinoma Xenograft in Nude Mice

1. Graduate School of Southern Medical University, Guangzhou 510515, China; 2. Department of Urology, Guangzhou General Hospital of Guangzhou Military Command,Guangzhou 510010, China

More Information

Received Date: September 18, 2014
Revised Date: November 24, 2014

Graphical Abstract

Abstract

Abstract

Objective To investigate the inhibitory effect of silencing PCAF gene in adrenocortical carcinoma SW13 cells on tumor growth and angiogenesis, and related mechanism. Methods pLenti6.3-MiRNA-PCAF recombinant lentivirus, and plenti6.3-MiRNA-NC recombinant lentivirus were used to infect the SW13 cells respectively. The infected and untreated cells were inoculated into 15 nude mice's oxter. Fifteen nude mice were randomized into experiment group, negative control group and blank control group. The infected SW13 cells and non-infected SW13 cells were respectively incubated into nude mice to induce the xenografts model. The tumor growth was observed. Western blot and real-time quantitive fluorescent PCR were used to test the protein and mRNA expression of PCAF in the xenografts. HE staining was applied to observe the morphologic changes of transplanted tumor. Immunohistochemical staining was used to detect the positive expression of VEGF and the microvessel density(MVD). Results The average tumor volume in the experiment group was significantly less than those in the negative control and blank control groups with an inhibitory rate of 49.2% and 52.9% respectively. Western blot and qPCR showed that the protein and mRNA expression of PCAF was decreased by 58.4% and 74.3% in the experiment group, compared with the negative control group. The expression of VEGF protein was significantly lower in the experiment group than those in the negative control and blank control groups. MVD was significantly lower in the experiment group(19.4±4.2) than those in the negative control(42.7±6.5) and blank control groups(51.3±8.6). Conclusion pLenti6.3- MiRNA-PCAF mediated by lentiviral vector could effectively inhibit the growth and angiogenesis of adrenocortical carcinoma xenograft in nude mice.
- P300/CBP associated factor(PCAF),
- Adrenocortical carcinoma,
- Angiogenesis,
- Vascular endothelial growth factor(VEGF),
- Xenograft

FullText(HTML)

References (17)

References

[1]	Chouairy CJ, Abdul-Karim F, Maclennan GT. Adrenocortical carcinoma[J]. J Urol, 2008, 179(1): 323.
[2]	Kuruba R, Gallagher SF. Current management of adrenal tumors[J]. Curr Opin Oncol, 2008, 20(1): 34-46.
[3]	Zhu C, Qin YR, Xie D, et al. Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma[J]. Oncogene, 20 09, 28(31): 2821-8.
[4]	Nie QW. Apreliminary study of the impact of down-regulated PCAF on biological behavior of adredal cortex cell lines SW13 and its mechanisms[D]. Nan Fang Yi Ke Da Xue, 2014. [聂奇伟. 沉默基因PCAF对肾上腺皮质癌细胞株SW13生物学行为影响及其机制的初步研究[D]. 南方医科大学, 2014.]
[5]	Weidner N. Intratumor microvessel density as a prognostic factor in cancer[J]. Am J Pathol, 1995, 147(1): 9-19.
[6]	Menon V, Krishnamurthy SV. Adrenocortical carcinomas: a 12-year clinicopathologic study of 15 cases[J]. Indian J Pathol Microbiol, 20 06, 49(1): 7-11.
[7]	Ozda? H, Batley SJ, Försti A, et al. Mutation analysis of CBP and PCAF reveals rare inactivating mutations in cancer cell lines but not in primary tumours[J]. Br J Cancer, 2002, 87(10): 1162-5.
[8]	Regina S, Rollin J, Bléchet C, et al. Tissue factor expression in non-small cell lung cancer: relationship with vascular endothelial growth factor expression, microvascular density, and K-ras mutation[J]. J Thorac Oncol, 2008, 3(7): 689-97.
[9]	Cai RX, Sheng X, Yuan ZH, et al. Expression of CD105, COX-2 and VEGF and their relationship with angiogenesis in colorectal carcinoma[J]. Zhong Liu Fang Zhi Yan Jiu, 2007, 34(2): 125-7. [蔡瑞霞, 盛霞, 袁志浩, 等. CD105、COX-2和VEGF在结直肠癌中的表达及其与血管新生的关系[J]. 肿瘤防治研究, 2007, 34(2): 12 5-7.]
[10]	Holash J, Maisonpierre PC, Compton D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF[J]. Science, 1999, 284(5422): 1994-8.
[11]	Fukuda R, Hirota K, Fan F, et al. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells[J]. J Biol Chem, 2002, 277(41): 38205-11.
[12]	Wang GL, Jiang BH, Semenza GL. Effect of altered redox states on expression and DNA-binding activity of hypoxia-inducible factor 1[J]. Biochem Biophys Res Commun, 1995, 212(2): 550-6.
[13]	Lim JH, Lee YM, Chun YS, et al. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1a lpha[J]. Mol Cell, 2010, 38(6): 864-78.
[14]	Rajendran R, Garva R, Ashour H, et al. Acetylation mediated by the p300/CBP-associated factor determines cellular energy metabolic pathways in cancer[J]. Int J Oncol, 2013, 42(6): 1961-72.
[15]	Ying MZ, Wang JJ, Li DW, et al. The p300/CBP associated factor is frequently downregulated in intestinal-type gastric carcinoma and constitutes a biomarker for clinical outcome[J]. Cancer Biol Ther, 2010, 9(4): 312-20.
[16]	Hirano G, Izumi H, Kidani A, et al. Enhanced expression of PCAF endows apoptosis resistance in cisplatin-resistant cells[J]. Mol Cancer Res, 2010, 8(6): 864-72.
[17]	Shiota M, Yokomizo A, Tada Y, et al. P300/CBP-associated factor regulates Y-box binding protein-1 expression and promotes cancer cell growth, cancer invasion and drug resistance[J]. Cancer Sci, 20 10, 101(8): 1797-806.

[1]	CHEN Lijun, CHEN Jingqi, ZENG Bohang. Correlation of CD68⁺ Tumor-associated Macrophages Number with Ki-67 Expression and Prognosis of Patients with Primary Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2016, 43(9): 774-778. DOI: 10.3971/j.issn.1000-8578.2016.09.009
[2]	LI Wen, FENG Yanlin. Valuation of SUVmax, Ki-67, p53 and EGFR in Predicting Effect of Neoadjuvant Chemotherapy on Triple-negative Breast Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2016, 43(1): 45-47. DOI: 10.3971/j.issn.1000-8578.2016.01.010
[3]	YAN Su, LI Bin, MA Xuxiang, MA Yingcai, XIONG Yuanzhi, GUO Xinjian, MA Yubin, YU Pengjie, WU Junqi, XIE Dawei, ZHAO Junhui, WU Huixian. Clinicopathological Characteristics of Young Gastric Cancer Patients in Hehuang Valley[J]. Cancer Research on Prevention and Treatment, 2015, 42(05): 502-505. DOI: 10.3971/j.issn.1000-8578.2015.05.018
[4]	ZHANG Cui-cui, WANG Jing, LI Kai. Characteristics and Prognostic Analysis of 60 Young Patients with Lung Cancer[J]. Cancer Research on Prevention and Treatment, 2011, 38(03): 274-277. DOI: 10.3971/j.issn.1000-8578.2011.03.009
[5]	LIANG Xu-dong, SHI Xiao-feng, JIA Zong-qi. Detection andSignificance of PTEN, NFκB andKi-67 in Gastric Cancer[J]. Cancer Research on Prevention and Treatment, 2010, 37(03): 326-629. DOI: 10.3971/j.issn.1000-8578.2010.03.023
[6]	ZHONG Wei-ming, MA Li-ping, CAI Yong-lin, LIANG Wei, CHEN Wan-sheng, HUANG Zhuo, YU Hong, TAN Bi-fang. Relationship between Expression of Ki-67 Protein and Radiosensitivity of Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2010, 37(02): 195-196. DOI: 10.3971/j.issn.1000-8578.2010.02.019
[7]	SHI Guo-qing, ZHAO Kui, WANG Hong, LIU Mo-rong. Expression of Gastrin and Ki-67 in Gastric Cancer and Precancerous Pesions[J]. Cancer Research on Prevention and Treatment, 2009, 36(09): 756-758. DOI: 10.3971/j.issn.1000-8578.2009.09.011
[8]	HE Yan-jiao, LIU Zhao-xia, LI Hong-li, YU Jin, LI Guang. Expression and Significance of E-cadherin and Ki-67 in Colorectal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2007, 34(09): 699-702. DOI: 10.3971/j.issn.1000-8578.2529
[9]	ZHENG Lei, HAN Yue-wu. Antisense Oligodeoxyribonucleotide Target Ki-67 Inhibits Proliferation of Human Hepatocellucar Carcinoma Cell HEPG-7402 in Vitro[J]. Cancer Research on Prevention and Treatment, 2006, 33(12): 862-864. DOI: 10.3971/j.issn.1000-8578.354
[10]	DENG Jie, CAO Dun-wen, LIU Ming-qiu, ZHU Run-qing, CHEN Hong-lei, CHEN Dao-ying, WANG Ji-e. Expression of p73, PTEN and Ki-67 Proteins in Endometrioid Adenocarcinoma and Their Significance[J]. Cancer Research on Prevention and Treatment, 2006, 33(11): 811-813. DOI: 10.3971/j.issn.1000-8578.374

Cited By

Get Citation

PDF

XML

Article views (1431) PDF downloads (2689)

Turn off MathJax

Article Contents

Abstract

References

Inhibitory Effect of Silencing PCAF Gene on Growth and Angiogenesis of Human Adrenocortical Carcinoma Xenograft in Nude Mice

Abstract

References

Related Articles

Catalog

Download Center

Links

Contact Us

Inhibitory Effect of Silencing PCAF Gene on Growth and Angiogenesis of Human Adrenocortical Carcinoma Xenograft in Nude Mice

Abstract

References

Related Articles

Catalog

Download Center

Links

Contact Us

Export File

Citation

Format

Content